Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report) saw a large increase in short interest in October. As of October 15th, there was short interest totalling 56,500 shares, an increase of 228.5% from the September 30th total of 17,200 shares. Based on an average daily trading volume, of 58,800 shares, the short-interest ratio is currently 1.0 days.
Fresenius SE & Co. KGaA Price Performance
Shares of FSNUY stock traded down $0.03 during trading hours on Friday, reaching $9.11. The company had a trading volume of 25,057 shares, compared to its average volume of 27,428. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.00 and a current ratio of 1.29. The stock has a fifty day moving average of $9.28 and a 200-day moving average of $8.38. The company has a market capitalization of $20.34 billion, a price-to-earnings ratio of 12.24 and a beta of 1.05. Fresenius SE & Co. KGaA has a 12-month low of $6.33 and a 12-month high of $9.78.
Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report) last released its quarterly earnings results on Wednesday, July 31st. The company reported $0.22 EPS for the quarter. The firm had revenue of $5.83 billion for the quarter. On average, equities analysts anticipate that Fresenius SE & Co. KGaA will post 0.84 earnings per share for the current year.
About Fresenius SE & Co. KGaA
(
Get Free Report)
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Fresenius SE & Co. KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius SE & Co. KGaA wasn't on the list.
While Fresenius SE & Co. KGaA currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
